Mostrar el registro sencillo del ítem

dc.contributor.authorGalocha-León, Cristina
dc.contributor.authorSntich Acedo, Cristina
dc.contributor.authorClares Naveros, Beatriz 
dc.contributor.authorVoltes Martínez, Ana
dc.contributor.authorMarchal Corrales, Juan Antonio 
dc.contributor.authorGálvez Martín, Patricia
dc.date.accessioned2024-11-19T08:05:16Z
dc.date.available2024-11-19T08:05:16Z
dc.date.issued2024-11-07
dc.identifier.citationGalocha León, C. et. al. Pharmaceutics 2024, 16, 1422. [https://doi.org/10.3390/pharmaceutics16111422]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/97053
dc.description.abstractBackground/Objectives: Three-dimensional bioprinting technology has enabled great advances in the treatment of articular cartilage (AC) defects by the biofabrication of biomimetic constructs that restore and/or regenerate damaged tissue. In this sense, the selection of suitable cells and biomaterials to bioprint constructs that mimic the architecture, composition, and functionality of the natural extracellular matrix (ECM) of the native tissue is crucial. In the present study, a novel cartilage-like biomimetic hybrid construct (CBC) was developed by 3D bioprinting to facilitate and promote AC regeneration. Methods: The CBC was biofabricated by the co-bioprinting of a bioink based on hyaluronic acid (HA) and alginate (AL) loaded with human mesenchymal stromal cells (hMSCs), with polylactic acid supporting the biomaterial, in order to mimic the microenvironment and structural properties of native AC, respectively. The CBC was biologically in vitro characterized. In addition, its physiochemical characteristics were evaluated in order to determine if the presence of hMSCs modified its properties. Results: Results from biological analysis demonstrated that CBC supported the high viability and proliferation of hMSCs, facilitating chondrogenesis after 5 weeks in vitro. The evaluation of physicochemical properties in the CBCs confirmed that the CBC developed could be suitable for use in cartilage tissue engineering. Conclusions: The results demonstrated that the use of bioprinted CBCs based on hMSC-AL/HA-bioink for AC repair could enhance the regeneration and/or formation of hyaline cartilaginous tissue.es_ES
dc.description.sponsorshipMinisterio de Economía, Industria y Competitividad (FEDER funds, project RTC-2016-5451-1)es_ES
dc.description.sponsorshipMinistry of Economy and Competitiveness, Instituto de Salud Carlos III (FEDER funds, projects DTS19/00143 and DTS17/00087)es_ES
dc.description.sponsorshipConsejería de Economía, Conocimiento, Empresas y Universidad de la Junta de Andalucía (P18-FR-2470, PYC20 RE 015 UGR, A-CTS-180-UGR20 and B-CTS-230-UGR18)es_ES
dc.description.sponsorshipFundación Mutua Madrileña (project FMM-AP17196-2019)es_ES
dc.description.sponsorshipAdvanceCat with the support of ACCIÓ (Catalonia Trade & Investment; Generalitat de Catalunya) under the Catalonian European Regional Development Fund operational program, 2014–2020es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjecthyaluronic acides_ES
dc.subjectmesenchymal stromal celles_ES
dc.subjectbioprintinges_ES
dc.titleDesign and Characterization of Biomimetic Hybrid Construct Based on Hyaluronic Acid and Alginate Bioink for Regeneration of Articular Cartilagees_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/pharmaceutics16111422
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional